SI1200447T1 - Oxazinocarbazoles for the treatment of cns diseases - Google Patents

Oxazinocarbazoles for the treatment of cns diseases

Info

Publication number
SI1200447T1
SI1200447T1 SI200030272T SI200030272T SI1200447T1 SI 1200447 T1 SI1200447 T1 SI 1200447T1 SI 200030272 T SI200030272 T SI 200030272T SI 200030272 T SI200030272 T SI 200030272T SI 1200447 T1 SI1200447 T1 SI 1200447T1
Authority
SI
Slovenia
Prior art keywords
oxazinocarbazoles
treatment
cns diseases
cns
diseases
Prior art date
Application number
SI200030272T
Other languages
Slovenian (sl)
Inventor
Ruth E. Tenbrink
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Priority claimed from PCT/US2000/019532 external-priority patent/WO2001009142A1/en
Publication of SI1200447T1 publication Critical patent/SI1200447T1/en

Links

SI200030272T 1999-07-28 2000-07-20 Oxazinocarbazoles for the treatment of cns diseases SI1200447T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14601399P 1999-07-28 1999-07-28
PCT/US2000/019532 WO2001009142A1 (en) 1999-07-28 2000-07-20 Oxazinocarbazoles for the treatment of cns diseases
EP00948738A EP1200447B1 (en) 1999-07-28 2000-07-20 Oxazinocarbazoles for the treatment of cns diseases

Publications (1)

Publication Number Publication Date
SI1200447T1 true SI1200447T1 (en) 2004-04-30

Family

ID=32178591

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030272T SI1200447T1 (en) 1999-07-28 2000-07-20 Oxazinocarbazoles for the treatment of cns diseases

Country Status (1)

Country Link
SI (1) SI1200447T1 (en)

Similar Documents

Publication Publication Date Title
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL145470A0 (en) Compositions for the treatment of immune diseases
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
EP1463527A4 (en) The use of gammaglobulin for the treatment of immune-mediated diseases
HUP0400024A3 (en) Combination for treatment of neoplastic diseases
HK1051485A1 (en) Treatment of hyperproliferative disorders
HUP0104963A3 (en) Compositions for the treatment of skin diseases
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL133760A0 (en) Composition for the treatment of dandruff
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
IL154378A0 (en) Compounds for the treatment of addictive disorders
PT1698338E (en) S-methyl-dihydro-ziprasidone for the treatment of schizophrenia
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
IL138691A (en) Process for the preparation of 3-acyl-indoles
GB0028484D0 (en) Imidazolone derivatives for the treatment of viral diseases
SI1200447T1 (en) Oxazinocarbazoles for the treatment of cns diseases
GB9904252D0 (en) Composition for the treatment of pain
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
GB9923551D0 (en) Treatment of neuropsychiatric disorders